ANDA 70819, held by Teva Pharmaceutical Industries. Metoclopramide Hydrochloride.
As of Nov 21, 2026, ANDA 70819 (Metoclopramide Hydrochloride), held by Teva Pharmaceutical Industries, was first approved by FDA on Jul 10, 1987, with 20 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 10, 1987 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metoclopramide HydrochlorideEQ 5MG BASE/5ML · solution;oral | Metoclopramide Hydrochloride | Discontinued |
| Sep 18, 1998 | Supplement 22Manufacturing | Approved | None posted |
| May 13, 1997 | Supplement 21Manufacturing | Approved | None posted |
| Mar 11, 1996 | Supplement 20Labeling | Approved | None posted |
| Feb 16, 1995 | Supplement 19Manufacturing | Approved | None posted |
| Sep 6, 1994 | Supplement 18Manufacturing | Approved | None posted |
| Mar 10, 1994 | Supplement 17Labeling | Approved | None posted |
| Dec 6, 1993 | Supplement 16Manufacturing | Approved | None posted |
| Sep 21, 1993 | Supplement 15Labeling | Approved | None posted |
| Jun 2, 1993 | Supplement 13Manufacturing | Approved | None posted |
| Mar 18, 1993 | Supplement 14Labeling | Approved | None posted |
| Jun 17, 1992 | Supplement 12Labeling | Approved | None posted |
| Mar 12, 1991 | Supplement 11Labeling | Approved | None posted |
| Sep 6, 1990 | Supplement 9Labeling | Approved | None posted |
| Mar 14, 1989 | Supplement 8Labeling | Approved | None posted |
| Jan 18, 1989 | Supplement 7Manufacturing | Approved | None posted |
| Jun 6, 1988 | Supplement 6Manufacturing | Approved | None posted |
| May 5, 1988 | Supplement 5Manufacturing | Approved | None posted |
| Oct 26, 1987 | Supplement 1Manufacturing | Approved | None posted |
| Sep 30, 1987 | Supplement 3Manufacturing | Approved | None posted |
| Sep 30, 1987 | Supplement 2Manufacturing | Approved | None posted |
| Jul 10, 1987 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters